Cost-Effectiveness of Population-Based Genetic Hemochromatosis Screening

Publisher： Karger

E-ISSN： 1662-8063|3|1|2-11

ISSN： 1662-4246

Source： Public Health Genomics, Vol.3, Iss.1, 2000-09, pp. : 2-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes

By  

Public Health Genomics, Vol. 13, Iss. 7-8, 2010-01 ,pp. : 449-456

Karger

Access to resources Recommend Favorite

DNA Analysis of the Fragile X Syndrome in an at Risk Pediatric Population in Croatia: Simple Clinical Preselection Criteria Can Considerably Improve the Cost-Effectiveness of Fragile X Screening Studies

By  

Human Heredity, Vol. 48, Iss. 5, 1998-10 ,pp. : 256-265

Karger

Access to resources Recommend Favorite

The Cost Effectiveness of Screening Newborns for Congenital Adrenal Hyperplasia

By  

Public Health Genomics, Vol. 12, Iss. 2, 2008-09 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Genetic causes of intellectual disability in a birth cohort: A population‐based study

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 6, 2015-06 ,pp. : 1204-1214

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carrier screening by next‐generation sequencing: health benefits and cost effectiveness

By  

Molecular Genetics & Genomic Medicine, Vol. 4, Iss. 3, 2016-05 ,pp. : 292-302

John Wiley & Sons Inc

Access to resources Recommend Favorite